Boston Scientific missed analyst estimates for profit per share and cut its sales and profit forecasts for a third straight quarter. Cybersecurity cleanup costs and problems in Watchman and electrophysiology point to continuing business pressure; the inquiry concerns potential claims, not proven wrongdoing.
The repeated cuts suggest the company expects weaker sales and profits, not just a one-quarter miss. It cited cleanup costs from a cybersecurity incident and problems in two business areas. The investigation concerns potential claims, not a finding of wrongdoing, but it adds legal uncertainty.
Follow Boston Scientific Corporation (BSX) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for BSX